Remove topic formulation-and-drug-delivery-other
article thumbnail

Eyenovia and Formosa partner for new ophthalmic therapeutics

Pharmaceutical Technology

The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. The Optejet microdose formulation and delivery platform use Microdose Array Print (MAP) technology for delivering 6ml-8ml of the drug.

FDA 59
article thumbnail

mRNA therapeutics: a limitless revolution in medicine

European Pharmaceutical Review

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How long does it take ibuprofen to work?

The Checkup by Singlecare

Ibuprofen is a nonsteroidal anti-inflammatory drug ( NSAID ) that is available over the counter (OTC) and by prescription in higher doses. The time it takes for ibuprofen to work depends on the formulation, the route of administration, and whether you’re treating pain, fever, or inflammation. What is the standard ibuprofen dosage?

Dosage 105
article thumbnail

The vital role of conferences in pharmacy practice: a view from EBMT

Hospital Pharmacy Europe

Of course, hybrid events combine the best of both worlds and offer great flexibility and convenience whether you are a local attendee or sitting at your desk on the other side of the world. The conference landscape in a changing world Since the Covid-19 pandemic, the world of conferences has evolved. All have their pros and cons, however.

article thumbnail

Pharmaceutical industry: 2023 in retrospect

European Pharmaceutical Review

1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way to resolution.

FDA 96
article thumbnail

Pioneering gene therapy approval offers hope for dystrophic epidermolysis bullosa sufferers

Hospital Pharmacy Europe

The FDA approval of VYJUVEK – also known as beremagene geperpavec or B-VEC – provides the first novel topical gene therapy. The delivery of the functional genes within B-VEC is achieved after outer shell viral proteins interact with proteins on the surface of skin cells to facilitate viral nucleocapsid entry. Rod Tucker finds out more.

FDA 96
article thumbnail

Evaluating NMR relaxometry for antibody identification

European Pharmaceutical Review

This has led to applications with biopharmaceutical formulations and protein investigations. Of particular interest is the potential of using NMR relaxometry as a point of receipt technique to satisfy regulatory identity testing requirements for active pharmaceutical ingredients (API) and drug product materials.